Examkin

Soru

Zorluk: ZorMonitoring and Treatment Evaluation

A 67-year-old man comes to the cardiology clinic for a follow-up evaluation. Over the past 6 months, he has experienced four episodes of severe palpitations, shortness of breath, and fatigue, each lasting up to 12 hours. He has a history of hypertension, type 2 diabetes mellitus, and paroxysmal atrial fibrillation. Current medications include metoprolol succinate, apixaban, rosuvastatin, and lisinopril. His blood pressure is 132/82132/82 mmHg, and his pulse is 7878/min and irregularly irregular. An electrocardiogram confirms atrial fibrillation with a ventricular rate of 7676/min. The patient is highly symptomatic during his episodes, and after discussing the risks and benefits, the physician decides to initiate oral amiodarone for rhythm control. Which of the following parameters should be evaluated prior to initiating this therapy? (Select all that apply)

  1. Hepatic function panelCevap
  2. B
    Serum creatine kinase level
  3. C
    Prothrombin time and international normalized ratio
  4. Thyroid-stimulating hormone levelCevap
  5. E
    High-resolution computed tomography of the chest

Cevap

The necessary baseline parameters for amiodarone initiation are a hepatic function panel and a thyroid-stimulating hormone (TSH) level.
Amiodarone is a highly efficacious class III antiarrhythmic agent but is associated with multi-organ toxicity, necessitating comprehensive baseline and ongoing monitoring. Amiodarone contains iodine and can cause both hypothyroidism (via the Wolff-Chaikoff effect) and hyperthyroidism (via the Jod-Basedow phenomenon); therefore, a baseline thyroid-stimulating hormone (TSH) level is universally required. Additionally, it can cause transient, asymptomatic transaminitis or severe hepatotoxicity, mandating a baseline hepatic function panel. Standard baseline testing also includes an electrocardiogram and a standard chest radiograph.

Adım Adım Çözüm

1
Analyze the clinical scenario and the planned pharmacological intervention.
The patient is being started on oral amiodarone for the management of highly symptomatic paroxysmal atrial fibrillation.
Identifying the specific medication allows for the anticipation of its adverse effect profile and the determination of standard baseline monitoring requirements.
2
Identify the standard baseline monitoring parameters required for amiodarone.
Due to its multi-organ toxicity, amiodarone requires a baseline electrocardiogram, chest radiograph, thyroid-stimulating hormone (TSH) level, and hepatic function panel.
Amiodarone can induce QTc prolongation, interstitial pneumonitis, thyroid dysfunction (hypo- and hyperthyroidism), and hepatotoxicity.
3
Evaluate the incorrect options against the patient's current medication regimen to rule out inappropriate testing.
Routine CK monitoring is unnecessary because rosuvastatin does not carry the same CYP3A4 interaction risk as simvastatin. PT/INR monitoring is useless for evaluating apixaban. A baseline HRCT is excessively advanced imaging compared to a standard chest radiograph.
Understanding distinct pharmacokinetic interactions and appropriate diagnostic test sequencing prevents the ordering of unnecessary, high-cost, or low-yield investigations.

Anahtar Kavram

Baseline monitoring prior to amiodarone initiation mandates evaluation of pulmonary function (chest radiograph), thyroid function (TSH/Free T4), hepatic function (AST/ALT/bilirubin), and an electrocardiogram.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Monitoring and Treatment Evaluation

Bu konudan daha fazla soru